Federal Register of Legislation - Australian Government

Primary content

PB 55 of 2011 Specifications as made
This instrument amends the National Health (Pharmaceutical Benefits - Early Supply) Instrument 2009 - specification under subsection 84AAA(2) (No. PB 30 of 2009) that lists the medicines for which Pharmaceutical Benefits Scheme Safety Net entitlements will not apply when the next supply of the same medicine is obtained within 20 days.
Administered by: Health
Registered 28 Jul 2011
Tabling HistoryDate
Tabled HR18-Aug-2011
Tabled Senate18-Aug-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014



Instrument number PB 55 of 2011

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2011 - Specification Under Subsection 84AAA(2)


Amendment determination under subsection 84AAA(2) of the National Health Act 1953


I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.


Dated 22 July 2011




Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing




Amendment determination — Pharmaceutical Benefits - Early Supply



1          Name of Instrument


(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2011 - specification under subsection 84AAA(2).


(2)           This Instrument may also be cited as No. PB 55 of 2011.


2          Commencement


This Instrument commences on 1 August 2011.



3          Amendment of PB 30 of 2009


Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.


Schedule 1        Amendments


[1]                       Schedule 1, after item dealing with Dutasteride

insert in the columns in the order indicated:


Dutasteride with Tamsulosin

Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms